Federation Bio Launches With $50M Series A Financing And Expands Team To Pioneer Diverse Microbial Therapies
Federation Bio Launches with $50 Million Series A Financing and Expands Team to Pioneer Diverse Microbial Therapies
-- Federation Bio is developing microbial therapies comprising naturally occurring and genetically modified bacterial strains
-- Horizons Ventures led the financing, joined by Seventure Partners/Health for Life Capital, as well as existing investors, including Venrock and Altitude
-- Company appoints Dr. Emily Drabant Conley chief executive officer and expands board of directors to include Dr. Conley and Dr. John Stuelpnagel
SOUTH SAN FRANCISCO, Calif., October 6, 2020-- Federation Bio, a microbial therapeutics company targeting diseases in which the human microbiome can play a curative role ...